全文获取类型
收费全文 | 2412篇 |
免费 | 234篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 76篇 |
妇产科学 | 61篇 |
基础医学 | 297篇 |
口腔科学 | 76篇 |
临床医学 | 334篇 |
内科学 | 510篇 |
皮肤病学 | 26篇 |
神经病学 | 182篇 |
特种医学 | 287篇 |
外科学 | 247篇 |
综合类 | 83篇 |
预防医学 | 148篇 |
眼科学 | 51篇 |
药学 | 148篇 |
中国医学 | 3篇 |
肿瘤学 | 107篇 |
出版年
2021年 | 24篇 |
2019年 | 22篇 |
2018年 | 36篇 |
2017年 | 26篇 |
2016年 | 22篇 |
2015年 | 35篇 |
2014年 | 41篇 |
2013年 | 47篇 |
2012年 | 97篇 |
2011年 | 65篇 |
2010年 | 63篇 |
2009年 | 49篇 |
2008年 | 78篇 |
2007年 | 68篇 |
2006年 | 65篇 |
2005年 | 81篇 |
2004年 | 75篇 |
2003年 | 50篇 |
2002年 | 62篇 |
2001年 | 65篇 |
2000年 | 69篇 |
1999年 | 65篇 |
1998年 | 64篇 |
1997年 | 80篇 |
1996年 | 68篇 |
1995年 | 67篇 |
1994年 | 59篇 |
1993年 | 45篇 |
1992年 | 67篇 |
1991年 | 53篇 |
1990年 | 54篇 |
1989年 | 54篇 |
1988年 | 64篇 |
1987年 | 50篇 |
1986年 | 58篇 |
1985年 | 52篇 |
1984年 | 35篇 |
1983年 | 34篇 |
1982年 | 36篇 |
1981年 | 31篇 |
1978年 | 23篇 |
1977年 | 33篇 |
1976年 | 31篇 |
1974年 | 33篇 |
1973年 | 21篇 |
1972年 | 36篇 |
1971年 | 29篇 |
1970年 | 36篇 |
1969年 | 30篇 |
1966年 | 27篇 |
排序方式: 共有2653条查询结果,搜索用时 31 毫秒
61.
62.
Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
Denise H Frank Denise J Roe H-H Sherry Chow Jose M Guillen Karin Choquette Debra Gracie Jennifer Francis Airley Fish David S Alberts 《Cancer epidemiology, biomarkers & prevention》2004,13(2):299-303
A combination of celecoxib and selenium was used in a randomized double-blind Phase II trial as a preliminary study to a multicenter Phase III colorectal cancer chemoprevention trial using these two agents together. The purpose of this trial was to determine whether high-selenium baker's yeast [(Saccharomyces cerevisiae) 200 microg once daily] in combination with celecoxib (400 mg once daily) altered the steady-state plasma concentration of celecoxib or produced clinically significant toxicities. Seventy-three healthy subjects (ages 40-75 years) were recruited to the 6-week study from the general local population and were randomized to either the celecoxib plus selenized baker's yeast group or the celecoxib plus placebo group after a 2-week run in period of celecoxib only. Blood samples were taken at baseline (to document that there was no evidence of celecoxib intake), after the 2-week run-in period on celecoxib to verify steady-state blood levels of this agent, and at end of study (4 weeks postrandomization). Toxicities were monitored at 2 weeks after initiation of celecoxib, at 4 weeks after initiation, and at the end of the study. Blood level concentrations of celecoxib did not differ between the two groups as determined by high-performance liquid chromatography analysis nor were there significant differences in blood chemistry values between the two groups. Subjects' self-report of general physical toxicities was uncommon and limited to National Cancer Institute toxicity grade 2 or less; however, 2 female participants (3%) were removed from the study medications because of grade 2 edema and significant weight gain after 2 and 2.5 weeks of celecoxib administration. In conclusion, high-selenium yeast and celecoxib can be taken at the described doses with minimum short-term negative effects. In future Phase III chemoprevention trials of celecoxib, weight gain should be carefully monitored, and participants should be made aware of this potential side effect before study entry. 相似文献
63.
Wang WS; Hsieh RK; Chiou TJ; Liu JH; Fan FS; Yen CC; Tung SL; Chen PM 《Japanese journal of clinical oncology》1998,28(9):551-554
A 54-year-old man was treated with weekly 24-h infusion of high-dose
5-fluorouracil (2600 mg/m2) and leucovorin (100 mg/m2) for metastatic colon
cancer. At first, he tolerated the treatment well and no significant
toxicity was identified. After a total of eight courses of treatment, a
stable disease was observed, but mild shortness of breath was found on
occasion. The patient had no previous history of cardiac disease and the
heart performance assessed by left ventricular ejection fraction before
treatment was normal. Unfortunately, acute pulmonary edema with lethal
cardiogenic shock occurred during the ninth course of treatment, in spite
of intensive medical treatment. The chest X-ray showed extreme
cardiomegaly. Repeated assessment of his heart function by echocardiogram
and ventricular ejection fraction revealed a very poor cardiac performance.
Toxic cardiogenic shock during weekly 24-h infusion of high-dose
5-fluorouracil and leucovorin is extremely rare. To the best of our
knowledge, no case has been reported in the English literature. We report a
case and the relevant literature about the incidence, clinical picture and
possible pathophysiology on 5-fluorouracil-related cardioxicity is
reviewed.
相似文献
64.
Remote memory in epilepsy 总被引:3,自引:0,他引:3
PURPOSE: There is now a considerable amount of research relating to memory functioning in epilepsy. The majority of studies have focused on the retention of new information, and few reports have measured memory for past events. This study aims to redress this and measure the efficiency of remote memory in epilepsy. METHODS: A remote memory questionnaire was prepared and administered to three groups of patients with epilepsy and a control group without epilepsy. The questionnaire assessed knowledge of public events that occurred between 1980 and 1991, inclusive. The epilepsy groups comprised 33 patients with temporal lobe epilepsy (TLE), 33 with extratemporal epilepsy (ExTE), and 10 with primary generalized epilepsy (PGE). Thirty control subjects were tested. RESULTS: Patients with TLE performed significantly less well on the questionnaire than all other groups (p = 0.001), but no effect of laterality was recorded; patients with extratemporal or primary generalised epilepsy did not differ from controls. Performance on the questionnaire was not determined by verbal IQ, educational achievement, social class, or drug treatment, but was related to the number of generalised convulsions that had occurred since 1980. The strongest neuropsychological predictors of performance on this questionnaire were measures of verbal memory. CONCLUSIONS: The study demonstrated weak memory for past events in patients with TLE, thereby providing evidence of a broader memory disturbance in this group than has been previously highlighted. A test of remote memory, such as the one designed for this study, is easy to administer and provides clinically important information not available from conventional neuropsychological tests. 相似文献
65.
Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. 总被引:2,自引:0,他引:2
Nicole Mittmann Sandra R Knowles Manuel Gomez Joel S Fish Robert Cartotto Neil H Shear 《Drug safety》2004,27(7):477-487
INTRODUCTION: Toxic epidermal necrolysis (TEN) is a life-threatening adverse drug reaction (ADR) that is primarily the result of drug exposure (incidence 0.4-1.3 per million person-years). Life-threatening ADRs such as TEN should be reported to ADR monitoring programmes, which collect reports for suspected ADRs and alert the public and medical practitioners to new drug hazards. In Canada, reports are made to the Canadian Adverse Drug Reaction Monitoring Program (CADRMP). OBJECTIVE: To examine the extent of under-reporting for TEN in Canada. DESIGN: A retrospective case series design was used to collect all TEN cases for the period January 1995 to December 2000. METHODS: The CADRMP and 22 burn centres across Canada were contacted for all TEN patients treated during the specified time period. PATIENT GROUPS STUDIED: The study population consisted of patients admitted to burn treatment sites across Canada, patient cases reported to the CADRMP and patient cases recorded by the Canadian Institute for Health Information (CIHI) hospital discharge summaries as the International Classification of Diseases Version 9 Clinical Modification (ICD-9-CM) code 695.1. RESULTS: Twenty-five TEN cases (six fatal) were reported to CADRMP from January 1995 to December 2000. During this period, 14 (63.6%) burn treatment sites reported admission of 250 TEN cases. Hospital discharge summaries using the ICD-9-CM code 695.1 indicated that 4349 cases were admitted to hospital during this time period and it was estimated that 15.5% (n = 674) of these cases were TEN. Using the burn facility data as the denominator, 10% (25 of 250) of TEN cases were reported to CADRMP. Using CIHI data as a denominator, only 4% (25 of 674) of TEN cases were reported to CADRMP. CONCLUSIONS: There is serious under-reporting of TEN. Lack of reporting of life-threatening ADRs can compromise population safety. There is a need to increase awareness of ADR reporting programmes. 相似文献
66.
67.
68.
69.
Jennifer M. Trujillo Joseph J. Saseen Sunny A. Linnebur Laura M. Borgelt Brian A. Hemstreet Douglas N. Fish 《American journal of pharmaceutical education》2014,78(3)
Objective. To evaluate the impact of incorporating student-directed (SD) vs instructor-directed (ID) active learning on student performance in a pharmacotherapy capstone course.Design. This 9-credit course was redesigned from exclusively ID case discussions to a format in which half were SD and half were ID. Student performance on evaluation questions derived from SD sessions was compared with that from ID sessions.Assessment. Overall, students (n=299) performed better on ID-session questions than on SD-session questions (78.7% vs 75.3%, correctly answered, respectively; p<0.001). For written evaluations, students performed better on ID-session questions than on SD-session questions (79.8% vs 73.9%, respectively; p<0.001). For verbal evaluations, students performed better on SD-session questions than on ID-session questions (79.5% vs 74.5%, respectively; p<0.001). After the course revision, student confidence regarding their ability to think critically, solve problems, make decisions, and pursue lifelong learning was high, and student and faculty feedback was positive.Conclusion. Student performance in a pharmacotherapy capstone course remained acceptable when a combination of SD and ID active learning was used, but the addition of SD learning did not translate to better performance on course evaluations. 相似文献
70.